Stay updated with breaking news from Expansion Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BMF-219 is an investigational novel covalent menin inhibitor developed to regenerate insulin-producing beta cells with the aim to cure diabetes The first two type 1 diabetes patients enrolled in...
Construction continues at Charlotte-Douglas as part of their ongoing massive expansion project.
The first phase involves building a 450,000-square-foot warehouse and 61,535-square-foot return center.
51 wet AMD patients with severe disease activity and high treatment burden were randomized to high or low dose 4D-150 or aflibercept control regimen4D-150 was well tolerated with a favorable...
51 wet AMD patients with severe disease activity (mean of 442 µm central subfield thickness & presence of retinal fluid) and high treatment burden...